[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Jazz Pharma Plc (JAZZ)

Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences

DUBLIN , May 12, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that company management will participate in fireside chats at the following investor conferences:

JAZZ : 239.30 (+0.78%)
Jazz Pharmaceuticals’s Q1 Earnings Call: Our Top 5 Analyst Questions

Jazz Pharmaceuticals’s Q1 Earnings Call: Our Top 5 Analyst Questions

JAZZ : 239.30 (+0.78%)
5 Stocks Our Top Technical Strategist is Tracking Now

From the pullback in refining stock PSX to the breakout in AI pick Corning, here’s what John Rowland is watching ahead of Friday’s livestream.

NVDA : 222.42 (+0.82%)
FSLR : 235.40 (+6.17%)
GLW : 179.32 (+1.98%)
PSX : 179.10 (-1.80%)
JAZZ : 239.30 (+0.78%)
SPY : 740.20 (+0.88%)
JOBY : 10.10 (+1.00%)
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why

Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why

JAZZ : 239.30 (+0.78%)
JAZZ Q1 Deep Dive: Oncology and Neuroscience Drive Double-Digit Revenue Growth, Eyes on Upcoming Approvals

JAZZ Q1 Deep Dive: Oncology and Neuroscience Drive Double-Digit Revenue Growth, Eyes on Upcoming Approvals

JAZZ : 239.30 (+0.78%)
Jazz: Q1 Earnings Snapshot

Jazz: Q1 Earnings Snapshot

JAZZ : 239.30 (+0.78%)
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q1 CY2026 Sales

Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q1 CY2026 Sales

JAZZ : 239.30 (+0.78%)
Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results

– Strong commercial execution across franchises with total revenues of $1.1 billion (+19% YoY) –

JAZZ : 239.30 (+0.78%)
Jazz Pharmaceuticals' Oncology Pipeline Momentum Meets the Reality of Legacy Franchise Erosion

Barchart Research What to Expect from JAZZ Earnings JAZZ Generated May 4, 2026 Current Price $208.06 EPS Estimate $$3.82 Consensus Rating Strong Buy Average Move 5.67% Jazz Pharmaceuticals' Oncology Pipeline...

JAZZ : 239.30 (+0.78%)
Jazz Pharmaceuticals (JAZZ) Q1 Earnings Report Preview: What To Look For

Jazz Pharmaceuticals (JAZZ) Q1 Earnings Report Preview: What To Look For

JAZZ : 239.30 (+0.78%)

Barchart Exclusives

Your Morning Coffee, on Uber: Investors Counting on an UBER Stock Turnaround Are Hoping That ‘Eats for the Way’ Pays Off
Uber might be one of Wall Street's favorite platform companies, but share prices have stumbled in 2026. The company needs its latest feature to restore investor confidence. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.